8-K Announcements
6Material company update
May 21, 2026·SEC
Material company update
May 19, 2026·SEC
Material company update
May 11, 2026·SEC
Hims & Hers Health, Inc.(HIMS)Earnings, Financials & Key Ratios
HIMS•NYSE
69.5× P/E·Price updated Jun 19, 2026
AboutHims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.Show more
- Revenue$2.35B+59.0%
- EBITDA$160M+102.7%
- Net Income$128M+1.8%
- EPS (Diluted)0.51-3.8%
- Gross Margin73.83%-7.1%
- EBITDA Margin6.82%+27.5%
- Operating Margin4.5%+7.3%
- Net Margin5.47%-35.9%
- ROE25.23%-17.9%
HIMS Key Insights
Hims & Hers Health, Inc. (HIMS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 84 (top 16%)
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 73.6%
- ✓Good 3Y average ROE of 16.3%
- ✓Efficient asset utilization: 1.1x turnover
✗Weaknesses
- ✗High debt to equity ratio of 2.3x
- ✗Trading more than 30% below 52-week high
- ✗Expensive at 16.9x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when HIMS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HIMS Price & Volume
Hims & Hers Health, Inc. (HIMS) stock price & volume — 10-year historical chart
Loading chart...
HIMS Growth Metrics
Hims & Hers Health, Inc. (HIMS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years73.63%
3 Years64.55%
TTM32.81%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-108.05%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-112.61%
Return on Capital
10 Years-31.62%
5 Years-11.42%
3 Years5.14%
Last Year9.44%
HIMS Recent Earnings
Hims & Hers Health, Inc. (HIMS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
May 11, 2026Metric
Actual
Est
EPS
$0.40-1676.7%
$0.03
Rev
$608M-1.4%
$617M
Q1 2026
Feb 23, 2026Metric
Actual
Est
EPS
$0.07+250.0%
$0.02
Rev
$618M-0.2%
$619M
Q4 2025
Nov 3, 2025Metric
Actual
Est
EPS
$0.06-33.3%
$0.09
Rev
$599M-3.1%
$618M
Q3 2025
Aug 4, 2025Metric
Actual
Est
EPS
$0.17-5.6%
$0.18
Rev
$545M-6.7%
$584M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 11, 2026 | $0.40vs $0.03-1676.7% | $608Mvs $617M-1.4% |
| Q1 2026 | Feb 23, 2026 | $0.07vs $0.02+250.0% | $618Mvs $619M-0.2% |
| Q4 2025 | Nov 3, 2025 | $0.06vs $0.09-33.3% | $599Mvs $618M-3.1% |
| Q3 2025 | Aug 4, 2025 | $0.17vs $0.18-5.6% | $545Mvs $584M-6.7% |
Based on last 12 quarters of dataView full earnings history →
HIMS Peer Comparison
Hims & Hers Health, Inc. (HIMS) competitors in Digital Health and Care Delivery — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 TDOC | 1.46B | 8.07 | -7.08 | -1.54% | -6.81% | -12.37% | 0.75 | |
 DOCS | 3.83B | 20.46 | 20.88 | 13.05% | 30.4% | 19.36% | 0.01 | |
 OPRX | 93.45M | 4.98 | 18.44 | 18.78% | 6.37% | 5.47% | 0.20 | |
 WELL | 144.78B | 206.65 | 148.67 | 35.82% | 12.31% | 3.49% | 0.49 | |
 NVO | 191.93B | 43.19 | 12.18 | 6.43% | 37.2% | 66.36% | 0.67 | |
 LLY | 1.04T | 1098.13 | 47.85 | 44.7% | 34.98% | 101.17% | 1.60 | |
 AMWL | 140.85M | 8.43 | -1.41 | -1.98% | -48.16% | -33.48% | 0.02 | |
 TALK | 872.74M | 5.21 | 130.25 | 22% | 0.49% | 1.03% |
Compare HIMS vs Peers
Hims & Hers Health, Inc. (HIMS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HIMS Income Statement
Hims & Hers Health, Inc. (HIMS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 82.56M | 148.76M | 271.88M | 526.92M | 872M | 1.48B | 2.35B | 2.37B |
Revenue Growth % | - | 80.18% | 82.77% | 93.81% | 65.49% | 69.33% | 59% | 32.81% |
Cost of Goods Sold | 37.95M | 39.31M | 67.38M | 118.19M | 157.05M | 303.38M | 614.26M | 766.76M |
COGS % of Revenue | 45.97% | 26.42% | 24.78% | 22.43% | 18.01% | 20.55% | 26.16% | - |
Gross Profit | 44.6M▲ 0% | 109.45M▲ 145.4% | 204.49M▲ 86.8% | 408.72M▲ 99.9% | 714.95M▲ 74.9% | 1.17B▲ 64.1% | 1.73B▲ 47.8% | 1.6B▲ 0% |
Gross Margin % | 54.03% | 73.58% | 75.22% | 77.57% | 81.99% | 79.45% | 73.83% | 67.64% |
Gross Profit Growth % | - | 145.38% | 86.84% | 99.87% | 74.92% | 64.09% | 47.76% | - |
Operating Expenses | 119.02M | 124.59M | 319.54M | 477.42M | 744.4M | 1.11B | 1.63B | 1.57B |
OpEx % of Revenue | 144.16% | 83.76% | 117.53% | 90.61% | 85.37% | 75.26% | 69.34% | - |
Selling, General & Admin | 119.02M | 113.36M | 249.56M | 370.78M | 576.32M | 846.61M | 1.19B | 1.24B |
SG&A % of Revenue | 144.16% | 76.2% | 91.79% | 70.37% | 66.09% | 57.34% | 50.78% | - |
Research & Development | 0 | 11.24M | 22.38M | 29.24M | 48.23M | 78.82M | 149.3M | 166.32M |
R&D % of Revenue | - | 7.55% | 8.23% | 5.55% | 5.53% | 5.34% | 6.36% | - |
Other Operating Expenses | 0 | 0 | 47.59M | 77.4M | 119.86M | 185.8M | 286.44M | 2M |
Operating Income | -74.41M▲ 0% | -15.14M▲ 79.6% | -115.04M▼ 659.7% | -68.7M▲ 40.3% | -29.45M▲ 57.1% | 61.9M▲ 310.2% | 105.61M▲ 70.6% | 31.25M▲ 0% |
Operating Margin % | -90.14% | -10.18% | -42.31% | -13.04% | -3.38% | 4.19% | 4.5% | 1.32% |
Operating Income Growth % | - | 79.65% | -659.65% | 40.29% | 57.13% | 310.18% | 70.61% | - |
EBITDA | -74.15M | -14.09M | -110.97M | -61.22M | -19.94M | 78.99M | 160.12M | 99.43M |
EBITDA Margin % | -89.82% | -9.47% | -40.81% | -11.62% | -2.29% | 5.35% | 6.82% | 4.2% |
EBITDA Growth % | - | 81% | -687.73% | 44.83% | 67.43% | 496.18% | 102.7% | -24.83% |
D&A (Non-Cash Add-back) | 260K | 1.06M | 4.08M | 7.47M | 9.52M | 17.09M | 54.5M | 68.18M |
EBIT | -71.61M | -15.14M | -115.04M | -68.7M | -29.45M | 61.9M | 105.61M | 31.66M |
Net Interest Income | -369K | -10K | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 369K | 10K | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | 2.44M | -2.84M | 4.25M | 2.99M | 7.88M | 9.81M | 18.31M | -69.37M |
Pretax Income | -71.97M▲ 0% | -17.99M▲ 75.0% | -110.8M▼ 516.0% | -65.71M▲ 40.7% | -21.57M▲ 67.2% | 71.71M▲ 432.4% | 123.92M▲ 72.8% | -38.12M▲ 0% |
Pretax Margin % | -87.18% | -12.09% | -40.75% | -12.47% | -2.47% | 4.86% | 5.28% | -1.61% |
Income Tax | 90K | 127K | -3.14M | -31K | 1.98M | -54.33M | -4.44M | -24.89M |
Effective Tax Rate % | -0.13% | -0.71% | 2.83% | 0.05% | -9.16% | -75.76% | -3.58% | 65.28% |
Net Income | -72.06M▲ 0% | -18.11M▲ 74.9% | -107.66M▼ 494.3% | -65.68M▲ 39.0% | -23.55M▲ 64.1% | 126.04M▲ 635.3% | 128.37M▲ 1.8% | -13.23M▲ 0% |
Net Margin % | -87.29% | -12.18% | -39.6% | -12.46% | -2.7% | 8.54% | 5.47% | -0.56% |
Net Income Growth % | - | 74.86% | -494.34% | 38.99% | 64.15% | 635.28% | 1.85% | -108.05% |
Net Income (Continuing) | -72.06M | -18.11M | -107.66M | -65.68M | -23.55M | 126.04M | 128.37M | -13.23M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -2.07▲ 0% | -0.51▲ 75.4% | -0.58▼ 13.7% | -0.32▲ 44.8% | -0.11▲ 65.6% | 0.53▲ 581.8% | 0.51▼ 3.8% | -0.06▲ 0% |
EPS Growth % | - | 75.36% | -13.73% | 44.83% | 65.63% | 581.82% | -3.77% | -112.61% |
EPS (Basic) | -2.07 | -0.51 | -0.58 | -0.32 | -0.11 | 0.58 | 0.57 | - |
Diluted Shares Outstanding | 34.76M | 35.35M | 186.78M | 204.52M | 209.34M | 236.81M | 258.23M | 228.36M |
Basic Shares Outstanding | 34.76M | 35.35M | 186.78M | 204.52M | 209.34M | 215.94M | 224.96M | 228.36M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
HIMS Balance Sheet
Hims & Hers Health, Inc. (HIMS) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 69.61M | 113.08M | 269.9M | 216.59M | 265.05M | 395.83M | 767.64M | 1.05B |
Cash & Short-Term Investments | 60.37M | 100.21M | 247.27M | 179.63M | 220.98M | 300.25M | 577.49M | 750.88M |
Cash Only | 22.65M | 27.34M | 71.78M | 46.77M | 96.66M | 220.58M | 228.62M | 222.27M |
Short-Term Investments | 37.72M | 72.86M | 175.49M | 132.85M | 124.32M | 79.67M | 348.88M | 528.61M |
Accounts Receivable | 859K | 750K | 3.58M | 3.23M | 6.75M | 6.08M | 32.15M | 149.62M |
Days Sales Outstanding | 3.8 | 1.84 | 4.8 | 2.24 | 2.82 | 1.5 | 5 | 8.85 |
Inventory | 4.22M | 3.54M | 13.56M | 21.56M | 22.46M | 64.43M | 115.73M | 84.71M |
Days Inventory Outstanding | 40.56 | 32.9 | 73.44 | 66.59 | 52.21 | 77.51 | 68.77 | 53.34 |
Other Current Assets | 480K | 5.89M | 890K | 1.78M | 4.2M | 8.9M | 4.37M | 10.61M |
Total Non-Current Assets | 2.46M | 5.61M | 150.68M | 149.75M | 176.13M | 311.71M | 1.39B | 1.22B |
Property, Plant & Equipment | 0 | 0 | 5.11M | 16.14M | 45.73M | 92.96M | 448.98M | 478.09M |
Fixed Asset Turnover | - | - | 53.19x | 32.66x | 19.07x | 15.88x | 5.23x | 5.88x |
Goodwill | 0 | 0 | 110.88M | 110.88M | 110.88M | 112.73M | 278.32M | 342.84M |
Intangible Assets | 0 | 59K | 25.89M | 21.84M | 18.57M | 43.41M | 196.12M | 261.03M |
Long-Term Investments | 0 | 204.53M | 0 | 0 | 0 | 0 | 351.26M | 789.6M |
Other Non-Current Assets | 2.46M | -198.97M | 8.8M | 889K | 947K | 1M | 29.68M | 47.63M |
Total Assets | 72.07M▲ 0% | 118.7M▲ 64.7% | 420.58M▲ 254.3% | 366.34M▼ 12.9% | 441.19M▲ 20.4% | 707.54M▲ 60.4% | 2.15B▲ 204.5% | 2.27B▲ 0% |
Asset Turnover | 1.15x | 1.25x | 0.65x | 1.44x | 1.98x | 2.09x | 1.09x | 1.11x |
Asset Growth % | - | 64.7% | 254.34% | -12.9% | 20.43% | 60.37% | 204.54% | 920.35% |
Total Current Liabilities | 20.62M | 15.23M | 79.22M | 47.94M | 88.47M | 221.37M | 404.43M | 618.78M |
Accounts Payable | 7.23M | 8.07M | 19.64M | 32.36M | 43.07M | 91.18M | 143.28M | 306.87M |
Days Payables Outstanding | 69.54 | 74.9 | 106.38 | 99.94 | 100.1 | 109.7 | 85.14 | 89.68 |
Short-Term Debt | 1.51M | 0 | 0 | 0 | 0 | 0 | 4.84M | 5.58M |
Deferred Revenue (Current) | 753K | 1.27M | 3.19M | 1.47M | 7.73M | 75.28M | 127.16M | 509.17M |
Other Current Liabilities | 9.1M | 1.57M | 0 | 0 | 0 | 0 | 103.41M | 111.34M |
Current Ratio | 3.38x | 7.43x | 3.41x | 4.52x | 3.00x | 1.79x | 1.90x | 1.69x |
Quick Ratio | 3.17x | 7.19x | 3.24x | 4.07x | 2.74x | 1.50x | 1.61x | 1.55x |
Cash Conversion Cycle | -25.19 | -40.16 | -28.14 | -31.12 | -45.07 | -30.68 | -11.37 | -27.49 |
Total Non-Current Liabilities | 186.74M | 250.34M | 6.75M | 6.66M | 8.69M | 9.46M | 1.21B | 1.2B |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 1.12B | 974.11M |
Capital Lease Obligations | 0 | 0 | 4.12M | 3.65M | 8.67M | 9.46M | 143.17M | 510.88M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 28.86M | 83.58M |
Other Non-Current Liabilities | 186.74M | 250.34M | 2.63M | 3.01M | 22K | 0 | -78.42M | 52.13M |
Total Liabilities | 207.36M | 265.57M | 85.97M | 54.6M | 97.16M | 230.82M | 1.61B | 1.82B |
Total Debt | 1.51M | 0 | 5.48M | 5.31M | 9.95M | 11.35M | 1.26B | 1.13B |
Net Debt | -21.13M | -27.34M | -66.3M | -41.47M | -86.72M | -209.24M | 1.04B | 909.77M |
Debt / Equity | - | - | 0.02x | 0.02x | 0.03x | 0.02x | 2.34x | 2.54x |
Debt / EBITDA | - | - | - | - | - | 0.14x | 7.89x | 11.39x |
Net Debt / EBITDA | - | - | - | - | - | -2.65x | 6.46x | 9.15x |
Interest Coverage | -194.05x | -1514.40x | - | - | - | - | - | - |
Total Equity | -135.29M▲ 0% | -146.87M▼ 8.6% | 334.62M▲ 327.8% | 311.74M▼ 6.8% | 344.03M▲ 10.4% | 476.72M▲ 38.6% | 540.93M▲ 13.5% | 446.17M▲ 0% |
Equity Growth % | - | -8.56% | 327.83% | -6.84% | 10.36% | 38.57% | 13.47% | 82.18% |
Book Value per Share | -3.89 | -4.15 | 1.79 | 1.52 | 1.64 | 2.01 | 2.09 | 1.95 |
Total Shareholders' Equity | -135.29M | -146.87M | 334.62M | 311.74M | 344.03M | 476.72M | 540.93M | 446.17M |
Common Stock | 4.5M | 5K | 20K | 21K | 21K | 22K | 23K | 23K |
Retained Earnings | -153.18M | -171.29M | -278.95M | -344.63M | -368.18M | -242.14M | -113.77M | -205.89M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 2K | -11K | -137K | -277K | -124K | -324K | 2.29M | -4.41M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HIMS Cash Flow Statement
Hims & Hers Health, Inc. (HIMS) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | -74.87M | -2.48M | -34.41M | -26.53M | 73.48M | 251.08M | 300.01M | 283.66M |
Operating CF Margin % | -90.68% | -1.67% | -12.66% | -5.04% | 8.43% | 17.01% | 12.78% | - |
Operating CF Growth % | - | 96.69% | -1288.14% | 22.9% | 376.97% | 241.69% | 19.48% | -104.44% |
Net Income | -72.06M | -18.11M | -107.66M | -65.68M | -23.55M | 126.04M | 128.37M | -13.23M |
Depreciation & Amortization | 260K | 1.06M | 4.08M | 7.47M | 9.52M | 17.09M | 54.5M | 68.18M |
Stock-Based Compensation | 8.03M | 5.83M | 67.21M | 42.82M | 66.08M | 92.32M | 135.24M | 110.39M |
Deferred Taxes | 0 | 0 | -3.39M | -594K | -13K | -61.65M | -12.96M | -26.05M |
Other Non-Cash Items | -1.24M | 4.56M | 1.89M | 3.65M | 626K | -1.34M | 24.02M | 113.25M |
Working Capital Changes | -9.85M | 4.19M | 3.46M | -14.2M | 20.82M | 78.62M | -29.16M | 31.13M |
Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -116.25M |
Change in Inventory | -522K | 674K | -9.63M | -8M | -902K | -41.61M | -13.72M | -22.36M |
Change in Payables | -6.08M | 826K | 9.85M | 12.72M | 7.32M | 43.71M | 30.3M | 183.47M |
Cash from Investing | -39.3M | -39.7M | -156.27M | 34.7M | -12.11M | -19.05M | -1.02B | -1.01B |
Capital Expenditures | -308K | -1.74M | -832K | -2.71M | -17.22M | -41.66M | -226.04M | -207.04M |
CapEx % of Revenue | 0.37% | 1.17% | 0.31% | 0.52% | 1.97% | 2.82% | 9.63% | 8.74% |
Acquisitions | 0 | 0 | -46.47M | -459K | 0 | -15.4M | -145.23M | -277.99M |
Investments | - | - | - | - | - | - | - | - |
Other Investing | -1.48M | -2.5M | -4.17M | -4.53M | -9.27M | -11.1M | -16.55M | -12.84M |
Cash from Financing | 95.32M | 47.74M | 235.04M | -33.13M | -11.47M | -107.84M | 729.62M | 671.37M |
Debt Issued (Net) | -6.92M | -1.51M | 1.19M | 0 | 0 | 0 | 918.78M | 918.78M |
Equity Issued (Net) | 102.57M | 51.9M | 250.66M | 0 | -2M | -83.04M | -72.49M | -61.95M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | -22.03M | 0 | -2M | -83.04M | -89.96M | -89.96M |
Other Financing | -333K | -2.64M | -16.81M | -33.13M | -9.48M | -24.81M | -116.67M | -185.46M |
Net Change in Cash | -18.85M▲ 0% | 5.55M▲ 129.5% | 44.29M▲ 697.6% | -25.01M▼ 156.5% | 49.89M▲ 299.5% | 123.92M▲ 148.4% | 8.03M▼ 93.5% | -52.69M▲ 0% |
Free Cash Flow | -76.65M▲ 0% | -6.71M▲ 91.2% | -39.42M▼ 487.3% | -33.78M▲ 14.3% | 46.99M▲ 239.1% | 198.33M▲ 322.1% | 73.96M▼ 62.7% | 75.84M▲ 0% |
FCF Margin % | -92.85% | -4.51% | -14.5% | -6.41% | 5.39% | 13.43% | 3.15% | 3.2% |
FCF Growth % | - | 91.24% | -487.29% | 14.31% | 239.12% | 322.07% | -62.71% | -67.93% |
FCF per Share | -2.21 | -0.19 | -0.21 | -0.17 | 0.22 | 0.84 | 0.29 | 0.33 |
FCF Conversion (FCF/Net Income) | 1.04x | 0.14x | 0.32x | 0.40x | -3.12x | 1.99x | 2.34x | -5.73x |
Interest Paid | 361K | 10K | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 139K | 221K | 338K | 636K | 1.11M | 7.92M | 0 | 22.69M |
HIMS Key Ratios
Hims & Hers Health, Inc. (HIMS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | -114.69% | -20.32% | -7.18% | 30.71% | 25.23% | -2.48% |
Return on Invested Capital (ROIC) | - | -183.38% | -19.13% | -8.37% | 17.69% | 8.59% | 1.97% |
Gross Margin | 73.58% | 75.22% | 77.57% | 81.99% | 79.45% | 73.83% | 67.64% |
Net Margin | -12.18% | -39.6% | -12.46% | -2.7% | 8.54% | 5.47% | -0.56% |
Debt / Equity | - | 0.02x | 0.02x | 0.03x | 0.02x | 2.34x | 2.54x |
Interest Coverage | -1514.40x | - | - | - | - | - | - |
FCF Conversion | 0.14x | 0.32x | 0.40x | -3.12x | 1.99x | 2.34x | -5.73x |
Revenue Growth | 80.18% | 82.77% | 93.81% | 65.49% | 69.33% | 59% | 32.81% |
Related:HIMS Dividend History·HIMS Revenue History·HIMS Price History·HIMS P/E History·HIMS Financial Ratios·HIMS Institutional Holders
HIMS SEC Filings & Documents
Hims & Hers Health, Inc. (HIMS) SEC filings — annual & quarterly reports (10-K, 10-Q)
HIMS Frequently Asked Questions
Hims & Hers Health, Inc. (HIMS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Hims & Hers Health, Inc. (HIMS) reported $2.37B in revenue for fiscal year 2025. This represents a 2770% increase from $82.6M in 2019.
Hims & Hers Health, Inc. (HIMS) grew revenue by 59.0% over the past year. This is strong growth.
Hims & Hers Health, Inc. (HIMS) reported a net loss of $13.2M for fiscal year 2025.
Dividend & Returns
Hims & Hers Health, Inc. (HIMS) has a return on equity (ROE) of 25.2%. This is excellent, indicating efficient use of shareholder capital.
Hims & Hers Health, Inc. (HIMS) generated $75.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.